News & Events about Sorrento Therapeutics Inc.
PALO ALTO, Calif., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain ...
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company (Nasdaq: SCLX, Scilex...
In this article, we discuss the 5 hot healthcare stocks to buy now. If you want to read about some more hot healthcare stocks to buy now, go directly to 10 Hot Healthcare Stocks To Buy Now. 5. Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Number of Hedge Fund Holders: 10 YTD Perf: 167.99% Avg Volume: ...
PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc.(Nasdaq: SRNE, Sorrento) today posted a supplement to its previously issued Frequently Asked Questions document under the Investors section ...
SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc.(Nasdaq: SRNE, Sorrento) today posted a Frequently Asked Questions document under the Investors section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common ...